Reminder - American Municipal Income Portfolio (XAA) Goes Ex-Dividend Soon

Looking at the universe of stocks we cover at Dividend Channel, on 11/1/13, American Municipal Income Portfolio (XAA) will trade ex-dividend, for its monthly dividend of $0.08, payable on 11/20/13. As a percentage of XAA's recent stock price of $13.93, this dividend works out to approximately 0.57%, so look for shares of American Municipal Income Portfolio to trade 0.57% lower — all else being equal — when XAA shares open for trading on 11/1/13.

START SLIDESHOW:
Click here to learn which 25 S.A.F.E. dividend stocks should be on your radar screen »

Below is a dividend history chart for XAA, showing historical dividends prior to the most recent $0.08 declared by American Municipal Income Portfolio:

XAA+Dividend+History+Chart

In general, dividends are not always predictable; but looking at the history above can help in judging whether the most recent dividend from XAA is likely to continue, and whether the current estimated yield of 6.89% on annualized basis is a reasonable expectation of annual yield going forward.The chart below shows the one year performance of XAA shares, versus its 200 day moving average:

American Municipal Income Portfolio 200 Day Moving Average Chart

Looking at the chart above, XAA's low point in its 52 week range is $13.00 per share, with $19.08 as the 52 week high point — that compares with a last trade of $13.93.

In Wednesday trading, American Municipal Income Portfolio shares are currently trading flat on the day.

null

More from Stocks

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

3 Great Stock Market Sectors Millennials Should Invest In

3 Great Stock Market Sectors Millennials Should Invest In

Why Millennials Are Ditching Stocks for ETFs

Why Millennials Are Ditching Stocks for ETFs

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says